← Leaderboards
Dean Sheppard
University Of California San Francisco
$47,450,983
Attributed
$64,091,360
Total exposure
27
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$103,746,624 · 30
By mechanism
U19$21,632,339 · 4
R01$17,596,309 · 8
P01$14,969,672 · 3
T32$14,548,629 · 1
U01$13,632,680 · 3
P50$11,687,887 · 3
Top collaborators
- Laurence Huang14 shared
- David J Erle9 shared
- William F Degrado5 shared
- Jay Nadel5 shared
- Feroz R Papa5 shared
- Prescott G Woodruff3 shared
- Jose Rodriguez-Santana2 shared
- Luisa N Borrell1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Paul J Wolters$9,235,001
- Mohammed Kashani-Sabet$9,875,867
- Luanna K Putney$47,798
- David G Morris$859,525
Others in their field
Top investigators on “Integrins”
- Timothy A Springer · Boston Children'S Hospital$50,095,849
- David A Cheresh · Scripps Research Institute$28,587,859
- Mark Howard Ginsberg · University Of California, San Diego$28,221,483
- Martin A. Schwartz · Yale University$23,274,443
- M. Amin Arnaout · Massachusetts General Hospital$23,064,887
- Edward Franklin Plow · Cleveland Clinic Foundation$22,902,830
Research focus
IntegrinsResponsePathway InteractionsEpithelial CellsCellsLungIn VivoPlayMediatingProteinsSignal TransductionPulmonary FibrosisGrantFibrosisTissuesEpithelialDesignPreventBaseLeadCytokineLaboratory MouseTransforming Growth Factor BetaBleomycin
Grant awards (135)
Multidisciplinary Training Program in Lung Disease$1,316,196
T32 · FY2025 · HL
Induction, fate and function of inflammatory fibroblasts$774,757
R01 · FY2025 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,331,043
T32 · FY2024 · HL
Induction, fate and function of inflammatory fibroblasts$774,585
R01 · FY2024 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,254,303
T32 · FY2023 · HL
Fibroblast heterogeneity in pulmonary fibrosis$618,287
R01 · FY2023 · HL · contact PI
Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children$2,027,608
U01 · FY2022 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,243,626
T32 · FY2022 · HL · contact PI
Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis$697,743
R01 · FY2022 · HL · contact PI
Fibroblast heterogeneity in pulmonary fibrosis$618,287
R01 · FY2022 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$838,264
T32 · FY2021 · HL · contact PI
Fibroblast heterogeneity in pulmonary fibrosis$812,923
R01 · FY2021 · HL · contact PI
Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis$708,095
R01 · FY2021 · HL · contact PI
The effect of SARS-CoV-2 on the susceptibility of respiratory outcomes in a Puerto Rican Birth Cohort$646,280
U01 · FY2021 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,161,132
T32 · FY2020 · HL · contact PI
Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis$714,499
R01 · FY2020 · HL · contact PI
Fibroblast heterogeneity in pulmonary fibrosis$641,033
R01 · FY2020 · HL · contact PI
Fibroblast heterogeneity in pulmonary fibrosis$188,048
R01 · FY2020 · HL · contact PI
Caraballo Diversity Supplement 093019$113,853
R01 · FY2020 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,109,184
T32 · FY2019 · HL · contact PI
Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis$721,125
R01 · FY2019 · HL · contact PI
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.$1,517,775
UH3 · FY2018 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,073,074
T32 · FY2018 · HL · contact PI
20th Biennial International Conference on Lung and Airway Fibrosis (ICLAF)$30,000
R13 · FY2018 · HL
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.$1,555,009
UH3 · FY2017 · HL · contact PI
IL-13 and IL-17 dynamics in the asthmatic airway$1,521,253
U19 · FY2017 · AI · contact PI
Multidisciplinary Training Program in Lung Disease$1,043,093
T32 · FY2017 · HL · contact PI
Cytokine regulation of airway smooth muscle$557,335
U19 · FY2017 · AI · contact PI
Targeting epithelial cells to treat pulmonary fibrosis$2,553,585
P01 · FY2016 · HL · contact PI
IL-13 and IL-17 dynamics in the asthmatic airway$1,579,126
U19 · FY2016 · AI · contact PI
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.$1,446,327
UH3 · FY2016 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$782,132
T32 · FY2016 · HL · contact PI
Cytokine regulation of airway smooth muscle$481,708
U19 · FY2016 · AI · contact PI
Targeting epithelial cells to treat pulmonary fibrosis$2,470,358
P01 · FY2015 · HL · contact PI
IL-13 and IL-17 dynamics in the asthmatic airway$1,579,126
U19 · FY2015 · AI · contact PI
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.$1,025,193
UH2 · FY2015 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$879,894
T32 · FY2015 · HL · contact PI
Cytokine regulation of airway smooth muscle$481,708
U19 · FY2015 · AI · contact PI
Inhaled inhibitors of TGFB activation by integrins$397,977
P01 · FY2015 · HL · contact PI
Administration$179,227
P01 · FY2015 · HL · contact PI
Targeting Epithelial Cells To Treat Pulmonary Fibrosis$63,315
P01 · FY2015 · HL · contact PI
Targeting epithelial cells to treat pulmonary fibrosis$2,488,335
P01 · FY2014 · HL · contact PI
IL-13 and IL-17 dynamics in the asthmatic airway$1,680,602
U19 · FY2014 · AI · contact PI
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.$1,137,523
UH2 · FY2014 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$797,037
T32 · FY2014 · HL · contact PI
Inhaled inhibitors of TGFB activation by integrins$435,430
P01 · FY2014 · HL · contact PI
Cytokine regulation of airway smooth muscle$417,586
U19 · FY2014 · AI · contact PI
Integrin-mediated Regulation of Airway Smooth Muscle$378,525
R01 · FY2014 · HL · contact PI
Administration$164,794
P01 · FY2014 · HL · contact PI
Targeting epithelial cells to treat pulmonary fibrosis$2,431,465
P01 · FY2013 · HL · contact PI
IL-13 and IL-17 dynamics in the asthmatic airway$1,644,802
U19 · FY2013 · AI · contact PI
Multidisciplinary Training Program in Lung Disease$915,745
T32 · FY2013 · HL · contact PI
Inhaled inhibitors of TGFB activation by integrins$420,311
P01 · FY2013 · HL · contact PI
Cytokine regulation of airway smooth muscle$415,693
U19 · FY2013 · AI · contact PI
In Vivo Function of Pulmonary Integrins$383,248
R37 · FY2013 · HL · contact PI
Integrin-mediated Regulation of Airway Smooth Muscle$367,710
R01 · FY2013 · HL · contact PI
Administration$159,074
P01 · FY2013 · HL · contact PI
Targeting epithelial cells to treat pulmonary fibrosis$2,599,143
P01 · FY2012 · HL · contact PI
Mechanisms of Initiation and Persistence of Allergic Asthma$1,556,802
U19 · FY2012 · AI · contact PI
Multidisciplinary Training Program in Lung Disease$803,906
T32 · FY2012 · HL · contact PI
Inhaled inhibitors of TGFB activation by integrins$440,097
P01 · FY2012 · HL · contact PI
In Vivo Function of Pulmonary Integrins$402,578
R37 · FY2012 · HL · contact PI
Integrin-mediated Regulation of Airway Smooth Muscle$386,250
R01 · FY2012 · HL · contact PI
av Integrina in Cognate Immunity and Airway Hyperresponsiveness$369,612
U19 · FY2012 · AI · contact PI
Administration$166,561
P01 · FY2012 · HL · contact PI
Administration$136,502
U19 · FY2012 · AI · contact PI
Mechanisms of Initiation and Persistence of Allergic Asthma$1,546,847
U19 · FY2011 · AI · contact PI
In Vivo Function of Pulmonary Integrins$402,577
R37 · FY2011 · HL · contact PI
Integrin-mediated Regulation of Airway Smooth Muscle$386,250
R01 · FY2011 · HL · contact PI
av Integrina in Cognate Immunity and Airway Hyperresponsiveness$345,122
U19 · FY2011 · AI · contact PI
Administration$195,336
U19 · FY2011 · AI · contact PI
ENDOTHELIAL ALPHA V INTEGRIN COMPLEXES MODULATED ACTIN CYTOSKELETAL ORGANIZATION$9,360
P41 · FY2011 · RR · contact PI
Mechanisms of Initiation and Persistence of Allergic Asthma$1,779,612
U19 · FY2010 · AI · contact PI
In Vivo Function of Pulmonary Integrins$406,649
R37 · FY2010 · HL · contact PI
av Integrina in Cognate Immunity and Airway Hyperresponsiveness$398,205
U19 · FY2010 · AI · contact PI
Administration$225,182
U19 · FY2010 · AI · contact PI
ENDOTHELIAL ALPHA V INTEGRIN COMPLEXES MODULATED ACTIN CYTOSKELETAL ORGANIZATION$1,766
P41 · FY2010 · RR · contact PI
Mechanisms of Initiation and Persistence of Allergic Asthma$1,522,770
U19 · FY2009 · AI · contact PI
Mechanisms of Initiation and Persistence of Allergic Asthma$677,883
U19 · FY2009 · AI · contact PI
Regulation of Pulmonary Vascular Permeability by Integrin AlphaVBeta5$522,858
R01 · FY2009 · HL · contact PI
In Vivo Function of Pulmonary Integrins$402,857
R37 · FY2009 · HL · contact PI
Novel Leukocyte Integrins$346,963
R01 · FY2009 · AI · contact PI
av Integrina in Cognate Immunity and Airway Hyperresponsiveness$341,137
U19 · FY2009 · AI · contact PI
Administration$192,852
U19 · FY2009 · AI · contact PI
Mechanisms of Initiation and Persistence of Allergic Asthma$1,468,795
U19 · FY2008 · AI · contact PI
Regulation of Pulmonary Vascular Permeability by Integrin AlphaVBeta5$521,845
R01 · FY2008 · HL · contact PI
In Vivo Function of Pulmonary Integrins$359,123
R37 · FY2008 · HL · contact PI
Novel Leukocyte Integrins$347,217
R01 · FY2008 · AI · contact PI
av Integrina in Cognate Immunity and Airway Hyperresponsiveness$330,354
U19 · FY2008 · AI · contact PI
Integrin-Mediated Development of the Thoracic Duct$323,212
R01 · FY2008 · HL · contact PI
Administration$186,389
U19 · FY2008 · AI · contact PI
The NHLBI-Bay Area Functional Genomics Consortium$1,059,278
U01 · FY2007 · HL · contact PI
Regulation of Pulmonary Vascular Permeability by Integrin AlphaVBeta5$519,582
R01 · FY2007 · HL · contact PI
In Vivo Function of Pulmonary Integrins$359,123
R37 · FY2007 · HL · contact PI
Novel Leukocyte Integrins$354,188
R01 · FY2007 · AI · contact PI
Integrin-Mediated Development of the Thoracic Duct$323,212
R01 · FY2007 · HL · contact PI
Conference on Fibronectin, Integrins & Related Molecules$10,000
R13 · FY2007 · CA · contact PI
The NHLBI-Bay Area Functional Genomics Consortium$1,090,914
U01 · FY2006 · HL · contact PI
Regulation of Pulmonary Vascular Permeability by Integrin AlphaVBeta5$382,501
R01 · FY2006 · HL · contact PI
In Vivo Function of Pulmonary Integrins$369,849
R01 · FY2006 · HL · contact PI
Novel Leukocyte Integrins$365,005
R01 · FY2006 · AI · contact PI
Integrin-Mediated Development of the Thoracic Duct$332,865
R01 · FY2006 · HL · contact PI
Regulation of Pulmonary Vascular Permeability by Integrin AlphaVBeta5$127,431
R01 · FY2006 · HL · contact PI
Interactions of Lymphocytes, Cytokines and Airway Cells$1,983,807
P50 · FY2005 · HL
The NHLBI-Bay Area Functional Genomics Consortium$1,117,047
U01 · FY2005 · HL
In Vivo Function of Pulmonary Integrins$378,750
R01 · FY2005 · HL
Integrin-Mediated Development of the Thoracic Duct$340,875
R01 · FY2005 · HL
CORE--ANIMAL$286,288
P50 · FY2005 · HL
MODULATION OF AIRWAY INFLAMMATION BY EPITHELIAL INTEGRINS$286,288
P50 · FY2005 · HL
The NHLBI-Bay Area Functional Genomics Consortium$45,450
U01 · FY2005 · HL
Interactions of Lymphocytes, Cytokines and Airway Cells$1,952,747
P50 · FY2004 · HL
The NHLBI-Bay Area Functional Genomics Consortium$1,116,613
U01 · FY2004 · HL
In Vivo Function of Pulmonary Integrins$378,750
R01 · FY2004 · HL
Integrin-Mediated Development of the Thoracic Duct$340,875
R01 · FY2004 · HL
Interactions of Lymphocytes, Cytokines and Airway Cells$1,901,866
P50 · FY2003 · HL
THE NHLBI-BAY AREA FUNCTIONAL GENOMICS CONSORTIUM$1,555,968
U01 · FY2003 · HL
IN VIVO FUNCTION OF PULMONARY INTERGRINS$331,875
R01 · FY2003 · HL
ROLE OF A NEUTROPHIL INTEGRIN IN LUNG INFLAMMATION$282,740
R01 · FY2003 · HL
Interactions of Lymphocytes, Cytokines and Airway Cells$1,856,425
P50 · FY2002 · HL
THE NHLBI-BAY AREA FUNCTIONAL GENOMICS CONSORTIUM$1,626,627
U01 · FY2002 · HL
IN VIVO FUNCTION OF PULMONARY INTERGRINS$331,875
R01 · FY2002 · HL
ROLE OF A NEUTROPHIL INTEGRIN IN LUNG INFLAMMATION$275,925
R01 · FY2002 · HL
CORE--ANIMAL$172,411
P50 · FY2002 · HL
MODULATION OF AIRWAY INFLAMMATION BY EPITHELIAL INTEGRINS$172,411
P50 · FY2002 · HL
Interactions of Lymphocytes, Cytokines and Airway Cells$1,867,578
P50 · FY2001 · HL
THE NHLBI-BAY AREA FUNCTIONAL GENOMICS CONSORTIUM$1,656,822
U01 · FY2001 · HL
IN VIVO FUNCTION OF PULMONARY INTERGRINS$331,875
R01 · FY2001 · HL
ROLE OF A NEUTROPHIL INTEGRIN IN LUNG INFLAMMATION$269,310
R01 · FY2001 · HL
THE NHLBI-BAY AREA FUNCTIONAL GENOMICS CONSORTIUM$1,690,073
U01 · FY2000 · HL
MECHANISMS OF PERSISTENT AIRWAY INFLAMMATION IN ASTHMA$929,022
P50 · FY2000 · HL
IN VIVO FUNCTION OF PULMONARY INTEGRINS$331,875
R01 · FY2000 · HL
ROLE OF A NEUTROPHIL INTEGRIN IN LUNG INFLAMMATION$262,886
R01 · FY2000 · HL
SCIENTIFIC REVIEW AND EVALUATION GRANT$230,000
U09 · FY2000 · HL
CORE--ANIMAL$139,522
P50 · FY2000 · HL
MODULATION OF AIRWAY INFLAMMATION BY EPITHELIAL INTEGRINS$139,522
P50 · FY2000 · HL